Cellect(QNRX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results Quoin Broadens Product Portfolio through Research Agreement with University College Cork, Ireland Company Expands On-going Clinical Trials in Netherton Syndrome to Include International Sites Announced Plans to Initiate Clinical Study in Peeling Skin Syndrome Continues to Evaluate M&A Opportunities in Rare and Orphan Diseases ASHBURN, Va., August 8, 2024 -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNR ...